Us Diabetes Treatment Device Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Diabetes Treatment Device Market was valued at USD 10.5 Billion in 2022 and is projected to reach USD 19.5 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030.
The U.S. diabetes treatment device market is experiencing significant growth, driven by technological advancements and an increasing prevalence of diabetes. In 2023, the market was valued at approximately $9.53 billion and is projected to reach $15.21 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9%.
One notable development is Abbott Laboratories' performance in the medical devices sector. In the third quarter of 2024, Abbott reported $4.75 billion in sales, surpassing analysts' expectations. A significant contributor to this success was the strong demand for their glucose-monitoring products, particularly the FreeStyle Libre system, which saw a 21% organic growth with sales exceeding $1.6 billion. This surge is attributed to increased awareness of diabetes care and improved insurance coverage.
Insulet Corporation has also made remarkable strides with its Omnipod 5 insulin pump. Following its international launch, the company experienced a substantial boost in stock value. The FDA's clearance of their automated insulin delivery system for type 2 diabetes in August 2024 further solidified their market position. Insulet anticipates a 21%-22% growth in full-year Omnipod sales, driven by robust international demand and their pioneering role in automated insulin delivery systems for both type 1 and type 2 diabetes.
DexCom's collaboration with ÅŒURA marks another significant advancement in diabetes management. Announced in late 2024, this partnership aims to integrate DexCom's continuous glucose monitoring data with ÅŒURA's smart ring, which tracks heart rate, activity levels, sleep, and stress. This integration is expected to provide users with comprehensive health insights, enabling more informed decisions about their diet and activities. DexCom's over-the-counter sensor, launched in September 2024, has already achieved a $90 million annual sales rate, contributing to the company's projected $4 billion revenue for the year.
The market is also witnessing a trend where wellness enthusiasts are adopting continuous glucose monitors (CGMs) to optimize their health. Originally FDA-approved in 1999 for diabetes management, CGMs have become more accessible over-the-counter, leading to increased usage among non-diabetic individuals. For instance, elite cyclist Tracey Jacobs reported improved performance and reduced fatigue after monitoring her blood sugar levels with a CGM. Companies like Levels and Nutrisense are promoting CGM usage for better understanding of how daily habits impact health and performance. However, experts caution that the benefits of CGMs for non-diabetics are not yet conclusive, and excessive monitoring may lead to unhealthy behaviors.
Despite these advancements, the FDA has issued warnings against the use of unauthorized devices for diabetes management. In May 2019, the agency highlighted risks associated with unapproved continuous glucose monitoring systems, insulin pumps, and automated insulin dosing systems. The use of such unauthorized devices could result in inaccurate blood glucose measurements or unsafe insulin dosing, potentially leading to serious health complications. Patients are advised to consult healthcare professionals and use only FDA-approved devices to ensure safety and effectiveness.
In summary, the U.S. diabetes treatment device market is evolving rapidly, with key players like Abbott Laboratories, Insulet Corporation, and DexCom leading the charge through innovative products and strategic collaborations. As the market continues to grow, driven by technological advancements and a focus on comprehensive health management, it is crucial for patients and consumers to prioritize safety by choosing authorized devices and consulting healthcare professionals for personalized diabetes care.
Get an In-Depth Research Analysis of the Global Diabetes Treatment Device Market Size And Forecast [2025-2032]
Roche
Tandem Diabetes Care
Inc.
B. Braun Melsungen AG
Medtronic
BD
Novo Nordisk A/S
Abbott
Sanofi
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Diabetes Treatment Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Diabetes Treatment Device Market
Insulin Delivery Devices
Continuous Glucose Monitoring (CGM) Systems
Glycated Hemoglobin (HbA1c) Testing Devices
Diabetes Management Software
Pediatric (
Adult (18-65 years)
Geriatric (>65 years)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Direct Sales
Wearable Technology
Non-invasive Devices
Smartphone Integration
Cloud-based Solutions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Diabetes Treatment Device Market Research Analysis
1. Introduction of the Global Diabetes Treatment Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Diabetes Treatment Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Diabetes Treatment Device Market, By Type
6. Global Diabetes Treatment Device Market, By Application
7. Global Diabetes Treatment Device Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Diabetes Treatment Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/